Intervention not reported
Subjective fatigue severity (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Anxiety (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in anxiety (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Headache (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in headache (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
HRQOL (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Subjective impact of fatigue on ADL, fatigue severity (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Subjective impact of physical fatigue on ADL (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Subjective impact of mental fatigue on ADL (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Headache (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in headache (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Hypertension (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in hypertension (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Nausea (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in nausea (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Headache (adverse effect,post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in headache (adverse effect,post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Tachycardia (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in tachycardia (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Subjective impact of fatigue on ADL (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Subjective impact of physical fatigue on ADL (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Subjective impact of mental fatigue on ADL (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Subjective fatigue severity (post‐intervention) · people with Parkinson's disease
1 finding from 1 review
Intervention not reported
Anxiety (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in anxiety (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Headache (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in headache (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Hypertension (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in hypertension (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Nausea (adverse effect, post‐intervention) · people with Parkinson's disease
The intervention showed no clear difference in nausea (adverse effect, post‐intervention) (moderate certainty).
1 finding from 1 review